Emily Federmann

Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)

Jennifer H. Jordan, K. Ellenbogen, Thomas C. Crawford, 2021, Journal of Translational Medicine.

Preservation of Cardiac Reserve and Cardiorespiratory Fitness in Patients With Acute De Novo Versus Acute on Chronic Heart Failure With Reduced Ejection Fraction.

R. Arena, J. Canada, C. Trankle, 2021, The American journal of cardiology.

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

Dave L Dixon, G. Biondi-Zoccai, R. Arena, 2022, Journal of translational medicine.

Interleukin-1 Blockade in Cardiac Sarcoidosis: A Pilot Study.

K. Ellenbogen, Thomas C. Crawford, F. Bogun, 2023, Circulation. Arrhythmia and electrophysiology.